Toxicity & Biodistribution Study Demonstrates Safety of AAV-Mediated Human Beta-Sarcoglycan Gene Therapy

被引：0
|
作者：
Pozsgai, Eric [1 ]
Griffin, Danielle [1 ]
Heller, Kristin [1 ]
Mendell, Jerry [1 ]
Rodino-Klapac, Louise [1 ]
机构：
[1] Nationwide Childrens Hosp, Columbus, OH USA
来源：
MOLECULAR THERAPY | 2017年 / 25卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
40
引用
收藏
页码：19 / 20
页数：2
相关论文
共 50 条
  • [1] AAV-Mediated Gene Therapy for Atherosclerosis
    Michael Lehrke
    Corinna Lebherz
    Current Atherosclerosis Reports, 2014, 16
  • [2] AAV-Mediated Gene Therapy for Atherosclerosis
    Lehrke, Michael
    Lebherz, Corinna
    CURRENT ATHEROSCLEROSIS REPORTS, 2014, 16 (09)
  • [3] AAV-mediated gene therapy for fALS
    Cappella, M.
    Cohen-Tannoudji, M.
    Marais, T.
    Astord, S.
    Besse, A.
    Giroux, B.
    Barkats, M.
    Biferi, M. G.
    HUMAN GENE THERAPY, 2018, 29 (12) : A109 - A109
  • [4] AAV-mediated gene therapy for sialidosis
    van de Vlekkert, Diantha
    Hu, Huimin
    Weesner, Jason A.
    Fremuth, Leigh E.
    Brown, Scott A.
    Lu, Meifen
    Gomero, Elida
    Campos, Yvan
    Sheppard, Heather
    d'Azzo, Alessandra
    MOLECULAR THERAPY, 2024, 32 (07) : 2094 - 2112
  • [5] AAV-mediated gene therapy for hemophilia
    Couto, LB
    Pierce, GF
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2003, 5 (05) : 517 - 523
  • [6] AAV-mediated gene therapy for galactosialidosis: A long-term safety and efficacy study
    Fremuth, Leigh E.
    Hu, Huimin
    van de Vlekkert, Diantha
    Weesner, Jason A.
    Gomero, Elida M.
    d'Azzo, Alessandra
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 44 - 44
  • [7] AAV-mediated gene therapy for galactosialidosis: A long-term safety and efficacy study
    Hu, Huimin
    Mosca, Rosario
    Gomero, Elida
    van de Vlekkert, Diantha
    Campos, Yvan
    Fremuth, Leigh E.
    Brown, Scott A.
    Weesner, Jason A.
    Annunziata, Ida
    d'Azzo, Alessandra
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2021, 23 : 644 - 658
  • [8] Pre-Clinical Efficacy Study of Beta-Sarcoglycan Gene Transfer
    Pozsgai, Eric R.
    Grose, William E.
    Griffin, Danielle A.
    Heller, Kristin N.
    Mendell, Jerry R.
    Rodino-Klapac, Louise R.
    MOLECULAR THERAPY, 2013, 21 : S68 - S68
  • [9] AAV-mediated gene therapy of Pompe disease
    Ziegler, RJ
    Bercury, S
    Armentaro, D
    Raben, N
    Cheng, SH
    NEUROMUSCULAR DISORDERS, 2005, 15 (9-10) : 713 - 713
  • [10] Alpha- and beta-sarcoglycan delivery by AAV: Efficient rescue of muscle, but differential peristence of gene expression
    Dressman, D
    Araishi, K
    Imamura, M
    Sasaoka, T
    Liu, L
    Engvall, E
    Hoffman, EP
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 199 : S1 - S2
12345